Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20060292206 A1
Publication typeApplication
Application numberUS 10/301,061
Publication dateDec 28, 2006
Filing dateNov 20, 2002
Priority dateNov 26, 2001
Also published asUS8231665, US8231666, US8535367, US8562662, US8647377, US8936633, US9295569, US9561096, US9561097, US20070050008, US20070055355, US20070061005, US20120330343, US20130261724, US20140081374, US20140142685, US20140207226, US20160113659, US20160135945, US20170020653, WO2004045393A2, WO2004045393A3
Publication number10301061, 301061, US 2006/0292206 A1, US 2006/292206 A1, US 20060292206 A1, US 20060292206A1, US 2006292206 A1, US 2006292206A1, US-A1-20060292206, US-A1-2006292206, US2006/0292206A1, US2006/292206A1, US20060292206 A1, US20060292206A1, US2006292206 A1, US2006292206A1
InventorsSteven Kim, Brian Shiu, Neil Holmgren
Original AssigneeKim Steven W, Shiu Brian K, Neil Holmgren
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Devices and methods for treatment of vascular aneurysms
US 20060292206 A1
Abstract
The present invention relates to devices and methods for the treatment of diseases in the vasculature, and more specifically, devices and methods for treatment of aneurysms found in blood vessels. In a first embodiment of the present invention, a two part prostheses, where one part is an expandable sponge structure and the other part is an expandable tubular mesh structure, is provided. In the first embodiment, the expandable sponge structure is intended to fill the aneurysm cavity to prevent further dilatation of the vessel wall by creating a buffer or barrier between the pressurized pulsating blood flow and the thinning vessel wall. In the first embodiment, the expandable tubular mesh structure is placed across the aneurysm, contacting the inner wall of healthy vessel proximal and distal to the aneurysm.
Images(27)
Previous page
Next page
Claims(28)
1-32. (canceled)
33. A method for filling an aneurysm sac comprising,
placing a catheter configured to deliver a space-occupying device across an aneurysm cavity,
placing an expandable structure across the aneurysm cavity, wherein the space-occupying device is outside the catheter during the placing the expandable structure, and
filling the aneurysm sac with the space-occupying device.
34. The method of claim 33, wherein filling comprises placing the catheter into the aneurysm sac.
35. The method of claim 33, wherein filling further comprises inflating a balloon on the catheter after the catheter is placed across the aneurysm cavity.
36. (canceled)
37. The method of claim 35, wherein delivering the space-occupying device comprises pushing the space-occupying device along the catheter with a plunger.
38. The method of claim 33, wherein the space-occupying device comprises a sponge.
39. The method of claim 38, wherein filling comprises placing the catheter into the aneurysm sac.
40. The method of claim 33, wherein filling further comprises inflating a balloon on the catheter after the catheter is placed across the aneurysm cavity.
41. (canceled)
42. The method of claim 40, wherein delivering the device comprises pushing the device along the catheter with a plunger.
43. A method for filling an aneurysm cavity with a graft comprising an implant balloon, the method comprising,
positioning the graft at the aneurysm, wherein the graft is loaded radially outside a catheter, and wherein a first end of the graft is longitudinally concurrent with the catheter and wherein a second end of the graft is longitudinally concurrent with the catheter;
inflating the implant balloon, and
detaching and removing the catheter from the graft.
44. The method of claim 43, wherein inflating the balloon comprises inflating with an epoxy.
45. The method of claim 43, wherein inflating the balloon comprises inflating with silicone.
46. The method of claim 43, wherein inflating the balloon comprises inflating with urethane.
47. The method of claim 43, wherein inflating the balloon comprises inflating with albumin.
48. The method of claim 43, wherein inflating the balloon comprises inflating with collagen.
49. The method of claim 43, wherein inflating the balloon comprises inflating with gelatin glue.
50. The method of claim 43, wherein inflating the balloon comprises inflating with saline.
51. The method of claim 43, wherein inflating the balloon comprises inflating with a contrast agent.
52. The method of claim 43, wherein inflating the balloon comprises inflating with a biocompatible oil.
53. The method of claim 43, wherein inflating the balloon comprises inflating with a biocompatible adhesive.
54. The method of claim 43, wherein inflating the balloon comprises inflating with a UV-curable adhesive.
55. The method of claim 33, wherein the expandable structure comprises the space-occupying device.
56. The method of claim 33, wherein the space-occupying device comprises the balloon.
57. A method for filling an aneurysm sac comprising,
placing a catheter across an aneurysm cavity,
placing an expandable structure across the aneurysm cavity, and
filling the aneurysm sac with the space-occupying device:
wherein a space-occupying device is outside the catheter before the filling the aneurysm sac and after placing the expandable structure.
58. A method for filling an aneurysm sac comprising,
placing a catheter across an aneurysm cavity,
placing an expandable structure across the aneurysm cavity, wherein the space-occupying device is radially outside the catheter during the placing the expandable structure, and
filling the aneurysm sac with the space-occupying device.
59. A method for filling an aneurysm cavity with a graft comprising an implant balloon, the method comprising,
positioning the graft at the aneurysm, wherein the graft is loaded radially outside and substantially longitudinally concurrent with a catheter,
inflating the implant balloon, and
detaching and removing the catheter from the graft.
Description
    CROSS-REFERENCE TO RELATED APPLICATION
  • [0001]
    This application claims the benefit of U.S. Provisional Application No. 60/333,373, filed Nov. 26, 2001.
  • BACKGROUND OF THE INVENTION
  • [0002]
    The present invention relates to devices and methods for the treatment of diseases in the vasculature, and more specifically, devices and methods for treatment of aneurysms found in blood vessels. Aneurysms can occur in various areas of the cardiovascular system, but are commonly found in the abdominal aorta, thoracic aorta, and cerebral vessels. Aneurysms are unusual ballooning of the vessel due to loss of strength and/or elasticity of the vessel wall. With the constant pulsating pressure exerted on the vessel wall, the diseased or weakened wall can expand out and potentially rupture, which frequently leads to fatality. Prior methods of treating aneurysms have consisted of invasive surgical techniques. The technique involves a major cut down to access the vessel, and the diseased portion of the vessel is replaced by a synthetic tubular graft. Accordingly, this invasive surgical procedure has high mortality and morbidity rates.
  • [0003]
    Due to the inherent risks and complexities of the surgical procedures, various attempts have been made to develop minimally invasive methods to treat these aneurysms. For treatment of abdominal and thoracic aortic aneurysms, most of the attempts are catheter-based delivery of an endoluminal synthetic graft with some metallic structural member integrated into the graft, commonly called stent-grafts. One of the primary deficiencies of these systems is durability of these implants. Because catheter-based delivery creates limitations on size and structure of the implant that you can deliver to the target site, very thin synthetic grafts are attached to metallic structures, where constant interaction between the two with every heartbeat can cause wear on the graft. Also, the metallic structures often see significant cyclical loads from the pulsating blood, which can lead to fatigue failure of the metallic structure. The combination of a thin fragile graft with a metallic structure without infinite life capabilities can lead to implant failure and can ultimately lead to a fatality.
  • [0004]
    While the above methods have shown some promise with regard to treating aortic aneurysms with minimally invasive techniques, there remains a need for a treatment system which doesn't rely on the less than optimal combination of a thin graft and metallic structural member to provide long-term positive results. The present invention describes various embodiments and methods to address the shortcomings of current minimally invasive devices and to meet clinical needs.
  • SUMMARY OF THE INVENTION
  • [0005]
    In a first aspect, the present invention provides a two part prostheses where one part is an expandable sponge structure and the other part is an expandable tubular mesh structure. The expandable sponge structure is intended to fill the aneurysm cavity to prevent further dilatation of the vessel wall by creating a buffer or barrier between the pressurized pulsating blood flow and the thinning vessel wall. The expandable tubular mesh structure, which is placed across the aneurysm contacting the inner wall of healthy vessel proximal and distal to the aneurysm, serves two purposes. One, it defines the newly formed vessel lumen, even though it does not by itself provide a fluid barrier between the blood flow and the aneurysm. Two, it keeps the expandable sponge structure from protruding out of the aneurysm and into the newly formed vessel lumen. The expandable tubular mesh structure is delivered first across the aneurysm. Then, the expandable sponge structure is delivered via a catheter-based delivery system through a “cell” of the tubular mesh structure and into the aneurysm sac. When the sponge structure is deployed into the aneurysm sac and comes in contact with fluid, it will expand to a size larger than the largest opening or cell of the tubular mesh structure as to prevent the sponge structure from getting out of the aneurysm sac. The filled aneurysm sac will most likely clot off and prevent further dilation of the aneurysm and subsequent rupture. The blood flow should maintain a natural lumen where the luminal diameter is approximately defined by the diameter of the tubular mesh structure. The advantage of this system is that the sponge filler material acts like a graft but has unparalleled durability. The metallic structure can be optimized for durability as well because the size constraint is somewhat relieved due to the absence of an integrated graft material, which takes up a significant amount of space in a catheter.
  • [0006]
    In addition, the expandable sponge structure can be used to repair existing endoluminal stent-grafts which have developed leaks. There are thousands of endoluminal stent-grafts implanted into humans to treat abdominal aortic aneurysms. That number is growing daily. The endoluminal stent-grafts are intended to exclude the aneurysm from blood flow and blood pressure by placing a minimally porous graft supported fully or partially by metallic structural members, typically called stents. The acute success rate of these devices is very high, but there are a significant number of these which develop leaks, or blood flow/pressure re-entering the aneurysm sac, some time after the procedure. If the source of the leak can be accessed by the delivery system, the expandable sponge structure can be deployed through that access point.
  • [0007]
    In another aspect, the present invention provides an inflatable tubular balloon graft. It is a tubular graft, straight or bifurcated, where its wall is not a solid structure but a hollow chamber. The chamber can be filled with a variety of materials which can dictate the mechanical properties of the prostheses. The unfilled tubular balloon graft can be folded and loaded into a catheter-based delivery system, and once in position the tubular balloon graft can be “inflated” with the filler material. The material would be filled in a fluid form and may stay a fluid form or can be solidified by various means such as UV light, heat, and time. The advantage of this system is that a metallic structure is not needed to provide structure to the graft. It is instead replaced by the injectable fluid within the chamber of the tubular balloon graft. Customization of the mechanical properties of the graft is easily accomplished by using balloon fillers of varying properties.
  • [0008]
    The tubular balloon graft can be completely non-porous, completely porous with same degree of porosity throughout the graft, completely porous with varying porosity within the graft, or partially non-porous and partially porous. Significant porosity on the very outer layer would allow for delivery of an aneurysm sac filling substance or a drug. Porosity on the ends of the graft will help promote cellular in-growth. Porosity on the ends can also be used to deliver an adhesive so that the graft can be securely attached to the vessel wall.
  • [0009]
    Another embodiment of the tubular balloon graft includes a tubular balloon graft with a bulging outer layer. This will allow the outer surface of the tubular balloon graft to fill some or all of the aneurysm. This will provide a primary or secondary barrier for the aneurysm wall from the pulsating blood flow and will provide a means to prevent migration of the graft due to the enlarged area within the graft. An alternate method of construction would be to attach a bulging outer skin to a standard tubular thin-walled graft and provide a port for injection of the filler substance. Alternatively, instead of a bulging outer skin, a very compliant outer skin can be used so that the volume of material is minimized. The compliant outer skin would be able to expand at very low inflation pressures that would be non-destructive to the aneurysm wall.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0010]
    FIG. 1A illustrates the two-part prosthesis.
  • [0011]
    FIG. 1B illustrates a bifurcated version of the expandable tubular mesh structure and the expandable sponge structure.
  • [0012]
    FIG. 1C illustrates an expandable tubular mesh structure placed across an aneurysm and the expandable sponge structure filling up the aneurysm.
  • [0013]
    FIGS. 2A-2C illustrate the various cross-sections of the expandable sponge structure.
  • [0014]
    FIG. 3A illustrates a long continuous sponge structure.
  • [0015]
    FIG. 3B illustrates multiple short sponge structures.
  • [0016]
    FIG. 4 illustrates the catheter-based delivery system.
  • [0017]
    FIG. 5 illustrates a curved delivery catheter.
  • [0018]
    FIG. 6 illustrates a method of ensuring that the delivery catheter's tip stays inside the aneurysm sac.
  • [0019]
    FIG. 7A illustrates an expandable basket-like structure.
  • [0020]
    FIG. 7B illustrates an expandable braid-like structure.
  • [0021]
    FIGS. 8 and 9 illustrate expandable tubular mesh structures.
  • [0022]
    FIG. 10 illustrates a delivery catheter tracked over a guidewire and placed in a stent-graft which developed a leak.
  • [0023]
    FIG. 11 illustrates the sponge delivered through the delivery catheter.
  • [0024]
    FIGS. 12-15 illustrate tubular balloon grafts.
  • [0025]
    FIGS. 16 and 17 illustrate tubular balloon grafts being expanded.
  • [0026]
    FIG. 18 illustrates a tubular balloon graft.
  • [0027]
    FIGS. 19, 20A and 20B illustrate a vascular graft with an integrated tubular balloon.
  • [0028]
    FIGS. 21A-21E illustrate a method of delivering a graft with an external balloon.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0029]
    FIG. 1A shows the two-part prosthesis comprising of an expandable sponge structure 1 and an expandable tubular mesh structure 2 placed in an abdominal aortic aneurysm 3 located in the infra-renal aorta not involving the iliac arteries. FIG. 1B shows a bifurcated version of the expandable tubular mesh structure 2 and the expandable sponge structure 1 in an abdominal aortic aneurysm located in the infra-renal aorta and involving both iliac arteries. FIG. 1C shows an expandable tubular mesh structure 2 placed across an aneurysm commonly found in cerebral arteries and the expandable sponge structure 1 filling up the aneurysm. The expandable sponge structure 1 is placed through the expandable tubular mesh structure 2 into the aneurysm, filling up the aneurysmal sac which provides a barrier between the thin fragile wall of the aneurysm and the pressurized pulsating blood. The tubular mesh structure 2 keeps the expanded sponge 1 within the confines of the aneurysm and away from the flow path.
  • [0030]
    The expandable sponge structure 1 is preferably made of common medical grade polymers or natural substances like collagen which can be manufactured into a sponge structure. The sponge structure can be processed in such a way so that it can be compressed to a dry condition size substantially smaller than the wet condition size, exhibiting huge expansion ratio. The expanded sponge structure can take various forms. FIGS. 2A-2C show the various expanded cross-sections that the expandable sponge structure 1 can be. FIG. 2A shows a circular cross section, FIG. 2B shows a square cross section, and FIG. 2C show a triangular cross section. Any cross section can be used. The most important requirement is that it cannot escape from the aneurysm sac through a cell of the expandable tubular mesh structure 2. The length of the expandable sponge structure 1 can vary as well. FIG. 3A shows a long continuous structure 1. And FIG. 3B shows multiple short structures 1.
  • [0031]
    One method of delivering the sponge filler 1 into the aneurysm sac is shown by the catheter-based delivery system in FIG. 4. The catheter 4 can hold the compressed sponge 1 within its lumen, and when pushed out with the plunger 5 into the blood filled aneurysm sac, the sponge will expand out to a substantially larger size. The expanded size of the sponge filler is preferably larger than the largest opening of the tubular mesh structure as to prevent the sponge from escaping the aneurysm sac. FIG. 5 shows an example of a curved delivery catheter 4, where the tip is placed through a cell of the tubular mesh structure 2 and the expandable sponge structure 1 is being deployed into the aneurysm sac. It is important that the tip of the delivery catheter is through a cell of the tubular mesh structure into the aneurysm because the expandable sponge will expand very quickly after being exposed to the blood and being unconstrained by a catheter. FIG. 6 shows a method of ensuring that the delivery catheter's 4 tip stays inside the aneurysm sac by having a balloon 6 on the tip of it, and when inflated after the tip is within the aneurysm sac it will prevent the catheter tip from backing out of the aneurysm sac. FIG. 7A shows an expandable basket-like structure 7 and FIG. 7B shows an expandable braid-like structure 8 which are alternatives to having a balloon 6 on the tip of the catheter 4.
  • [0032]
    The expandable tubular mesh structure 2 can be made of a metal or of a polymer. The versions made of a metal can be self-expanding from a smaller compressed state or balloon expandable from a smaller compressed or as-cut state. The self-expanding version may be made of metals which exhibit large amounts of elasticity (i.e. nickel-titanium, spring steel, MP-35N and elgiloy) such that when they are compressed down from their expanded state to the compressed state to load into a delivery catheter, they will substantially return to their expanded condition when released from the catheter. Alternatively, shape memory metals like nickel-titanium can be used to provide large expansion ratios. The balloon expandable version may be made of metals which exhibit large permanent deformations without significantly compromising the mechanical performance. The following are some common medical grade metals which are well suited for this purpose: stainless steel, titanium, tantulum, and martensitic nickel titanium. In either the self-expanding or the balloon expandable case, the intent is to deliver the expandable tubular mesh 2 to the target site in a smaller or compressed condition via a catheter-based delivery system so that the target site can be accessed through a remote vascular access point which is conducive to a percutaneous or minimally invasive approach.
  • [0033]
    The expandable tubular mesh structure 2 shown in FIGS. 1A, 1B, 1C, 5, and 6 represent a generic mesh structure. FIG. 8 shows an expandable tubular mesh structure where long continuous struts 9 are connected to anchoring end members 10. This allows the structure to be very low in profile in the compressed state, and the durability of this type of structure can be optimized because no radial element exists in the longitudinal struts 9. FIG. 9 show an alternate expandable tubular mesh structure preferably made from a polymer such as PTFE, Polyester, Polyurethane, and the like. The structure has relatively large holes 11 to give access to the expandable sponge delivery catheter. The ends incorporate an anchoring member 12, either self-expanding or balloon expandable.
  • [0034]
    FIG. 10 shows a delivery catheter 4 which has been tracked over a guidewire 14, which has been placed into the aneurysm sac through an opening 15 of an existing endoluminal stent-graft 13 which developed a leak. The balloon 6 on the delivery catheter 4 was inflated after the delivery catheter 4 was positioned within the aneurysm sac. FIG. 11 shows the guidewire 14 removed, and the expandable sponge structure 1 being delivered through the delivery catheter 4.
  • [0035]
    FIG. 12 shows a section view of a tubular balloon graft 19 positioned across an infra-renal aortic aneurysm blocking off the flow to the aneurysm sac. The tubular balloon graft's 19 wall is made of an inner wall 16, an outer wall 17 and a chamber 18 between them. The chamber 18 can be filled with various materials to dictate the mechanical properties of the prosthesis. FIG. 13 shows a bifurcated tubular balloon graft 20 positioned across an infra-renal aortic aneurysm with bi-lateral iliac involvement.
  • [0036]
    The tubular balloon implant can be made of the various biocompatible materials used to make balloon catheters. Those materials include P.E.T. (Polyester), nylon, urethane, and silicone. It can also be made of other implant grade materials such as ePTFE. One method of making such a device is to start with two thin walled tubes of differing diameters. The difference between the diameters of the tubes will dictate the volume of the balloon chamber. The ends of the tubes can be sealed together with adhesive or by heat to form the balloon chamber. A communication port will be necessary to be able to fill the port with the injected material.
  • [0037]
    The injected material can be an epoxy, a UV-curable epoxy, silicone, urethane or other type of biocompatible materials such as albumin, collagen, and gelatin glue which is injected into the balloon, and then cured in situ. Or, the injected material doesn't necessarily have to be cured. The as-delivered state may provide the appropriate mechanical properties for the application. Therefore, substances like sterile saline, biocompatible oils, or biocompatible adhesives can be left in the tubular balloon in the as-delivered state.
  • [0038]
    The tubular balloon graft can be non-porous to very porous. FIG. 14 shows a version where the tubular balloon graft has a porous outer wall 24. The chamber 21 of the tubular balloon graft can be used to deliver an aneurysm sac filling substance such as UV curable adhesive 22. The holes 23 which dictate the porosity of the tubular balloon graft can be created with laser drilling, etching, and other methods. The porosity can be varied in select areas of the graft. FIG. 15 shows a tubular balloon graft with only the ends of the graft have porosity to either promote cellular in-growth or to inject an adhesive which allows secure attachment of the graft ends to the vessel wall.
  • [0039]
    FIG. 16 shows a tubular balloon graft 19 which is being expanded from a folded condition (not shown) by a balloon catheter 25. Once expanded, the chamber 18 of the tubular balloon graft 19 can be filled with the desired substance through the chamber access port 26. FIG. 17 shows a tubular balloon graft 19 being expanded by an inflation process or filling the chamber 18 of the tubular balloon graft 19 through the chamber access port 26.
  • [0040]
    FIG. 18 shows a version of the tubular balloon graft with an outer wall 17 which is substantially bulged out so that it fills some or all of the aneurysm sac. FIG. 19 shows a vascular graft 27 which has an integrated balloon 28 attached to the outside surface of the graft. The balloon can be pre-bulged and folded down for delivery, or it can be a very compliant material like silicone, urethane, or latex so that it has no folds whether compressed or expanded. FIG. 20A shows the same type of implant, a graft 27 with an external balloon 28, used in a cerebral vessel aneurysm 29. FIG. 20B show the same implant as 20A, except that the implant balloon does not fully fill the aneurysm, which can be acceptable because the graft 27 excludes the aneurysm from the blood flow, and the primary purpose of the balloon 28 is to prevent migration of the graft 27.
  • [0041]
    The graft 27 can be made of commonly used implant polymers such as PTFE, Polyester, Polyurethane, etc. The balloon 28 surrounding the graft can be made of the same commonly used vascular implant materials as well. The graft and balloon materials can be different, but it is commonly known that using the same material for both would facilitate processing/manufacturing. The theory is that the balloon 28 would preferentially only deploy into the aneurysm sac where the resistance to expansion is minimal as compared to the vessel wall. The graft 27 would provide the primary barrier between the pressurized blood and the thin wall of the aneurysm. Secondarily, the balloon itself provides a buffer from the pressurized blood. The balloon's 28 primary function, however, is to hold the graft 27 in place. Since the expanded section of the implant is “locked” into the aneurysm, the graft 27 should not migrate. Also, the balloon 28, in the filled state, will provide hoop strength to the graft 27.
  • [0042]
    FIGS. 21A-21E demonstrate one method of delivering a graft with an external balloon to the target site. FIG. 21A shows the implant loaded onto a balloon delivery catheter 30 with an outer sheath 32 and positioned over a guide wire 31 at the aneurysm target site. FIG. 21B shows that once in position, the outer sheath 32 is withdrawn. FIG. 21C shows the balloon delivery catheter 33 being inflated, pushing the implant 34 against the healthy vessel walls on both sides of the aneurysm. FIG. 21D shows that the balloon delivery catheter 30 may also have an implant balloon inflation port 35 which can now be used to fill up the implant balloon 28 with a biocompatible substance. The substance can be sterile saline, contrast agent, hydrogel, and UV cure adhesive to name a few. Most likely, low inflation pressures would be used to fill the implant balloon 28. FIG. 21E shows that once the implant balloon 28 is filled, the implant balloon inflation port 35 can be detached and the delivery catheter 30 removed.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4638803 *Nov 30, 1984Jan 27, 1987Rand Robert WMedical apparatus for inducing scar tissue formation in a body
US4641653 *Feb 19, 1985Feb 10, 1987Rockey Arthur GMedical sleeve
US4728328 *Jun 3, 1985Mar 1, 1988Research CorporationCuffed tubular organic prostheses
US4944745 *Feb 29, 1988Jul 31, 1990Scimed Life Systems, Inc.Perfusion balloon catheter
US5151105 *Oct 7, 1991Sep 29, 1992Kwan Gett CliffordCollapsible vessel sleeve implant
US5282824 *Jun 15, 1992Feb 1, 1994Cook, IncorporatedPercutaneous stent assembly
US5308356 *Feb 25, 1993May 3, 1994Blackshear Jr Perry LPassive perfusion angioplasty catheter
US5330528 *Nov 30, 1990Jul 19, 1994British Technology Group LimitedVascular surgical devices
US5395333 *Sep 1, 1993Mar 7, 1995Scimed Life Systems, Inc.Multi-lobed support balloon catheter with perfusion
US5478309 *May 27, 1994Dec 26, 1995William P. Sweezer, Jr.Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5530528 *Aug 10, 1993Jun 25, 1996Fujitsu LimitedImage forming apparatus having contact type, one-component developing unit
US5534024 *Nov 4, 1994Jul 9, 1996Aeroquip CorporationIntraluminal stenting graft
US5558642 *Feb 24, 1994Sep 24, 1996Scimed Life Systems, Inc.Drug delivery catheter
US5613981 *Apr 21, 1995Mar 25, 1997Medtronic, Inc.Bidirectional dual sinusoidal helix stent
US5665117 *Mar 21, 1996Sep 9, 1997Rhodes; Valentine J.Endovascular prosthesis with improved sealing means for aneurysmal arterial disease and method of use
US5693088 *Jun 7, 1995Dec 2, 1997Lazarus; Harrison M.Intraluminal vascular graft
US5769882 *Sep 8, 1995Jun 23, 1998Medtronic, Inc.Methods and apparatus for conformably sealing prostheses within body lumens
US5824037 *Oct 3, 1995Oct 20, 1998Medtronic, Inc.Modular intraluminal prostheses construction and methods
US5843160 *Apr 1, 1996Dec 1, 1998Rhodes; Valentine J.Prostheses for aneurysmal and/or occlusive disease at a bifurcation in a vessel, duct, or lumen
US5876448 *Mar 13, 1996Mar 2, 1999Schneider (Usa) Inc.Esophageal stent
US5925059 *Dec 21, 1994Jul 20, 1999Target Therapeutics, Inc.Detachable embolic coil assembly
US5935145 *Feb 13, 1998Aug 10, 1999Target Therapeutics, Inc.Vaso-occlusive device with attached polymeric materials
US5944733 *Jul 14, 1997Aug 31, 1999Target Therapeutics, Inc.Controlled detachable vasoocclusive member using mechanical junction and friction-enhancing member
US5980514 *Jul 26, 1996Nov 9, 1999Target Therapeutics, Inc.Aneurysm closure device assembly
US5984963 *Apr 23, 1996Nov 16, 1999Medtronic Ave, Inc.Endovascular stents
US5994750 *Nov 3, 1995Nov 30, 1999Canon Kabushiki KaishaMicrostructure and method of forming the same
US6096021 *Mar 30, 1999Aug 1, 2000The University Of Virginia Patent FoundationFlow arrest, double balloon technique for occluding aneurysms or blood vessels
US6110198 *Jan 5, 1999Aug 29, 2000Medtronic Inc.Method for deploying cuff prostheses
US6165194 *Jul 24, 1998Dec 26, 2000Micrus CorporationIntravascular flow modifier and reinforcement device
US6168592 *Apr 23, 1999Jan 2, 2001Target Therapeutics, Inc.Aneurysm closure device assembly
US6190402 *Jun 21, 1996Feb 20, 2001Musc Foundation For Research DevelopmentInsitu formable and self-forming intravascular flow modifier (IFM) and IFM assembly for deployment of same
US6193745 *Jun 4, 1997Feb 27, 2001Medtronic, Inc.Modular intraluminal prosteheses construction and methods
US6196230 *Sep 10, 1998Mar 6, 2001Percardia, Inc.Stent delivery system and method of use
US6261305 *Feb 12, 1999Jul 17, 2001Eclips Systems Inc.Endovascular prothesis with expandable leaf portion
US6273917 *Mar 27, 1998Aug 14, 2001Kanji InoueTransplantation device
US6283991 *Jul 22, 1998Sep 4, 2001Medtronics Inc.Endoluminal prostheses and therapies for highly variable body lumens
US6293960 *May 22, 1998Sep 25, 2001Micrus CorporationCatheter with shape memory polymer distal tip for deployment of therapeutic devices
US6296603 *May 26, 1998Oct 2, 2001Isostent, Inc.Radioactive intraluminal endovascular prosthesis and method for the treatment of aneurysms
US6299597 *Nov 25, 1997Oct 9, 2001Scimed Life Systems, Inc.Percutaneous repair of cardiovascular anomalies and repair compositions
US6312462 *Sep 22, 1999Nov 6, 2001Impra, Inc.Prosthesis for abdominal aortic aneurysm repair
US6312463 *Feb 1, 2000Nov 6, 2001Endotex Interventional Systems, Inc.Micro-porous mesh stent with hybrid structure
US6331184 *Dec 10, 1999Dec 18, 2001Scimed Life Systems, Inc.Detachable covering for an implantable medical device
US6334869 *Mar 14, 2000Jan 1, 2002World Medical Manufacturing CorporationEndoluminal prosthesis
US6344041 *Oct 26, 2001Feb 5, 2002David KupieckiAneurysm closure device assembly
US6358556 *Jan 23, 1998Mar 19, 2002Boston Scientific CorporationDrug release stent coating
US6458119 *Aug 8, 1997Oct 1, 2002Target Therapeutics, Inc.Ultrasoft embolism devices and process for using them
US6463317 *May 19, 1998Oct 8, 2002Regents Of The University Of MinnesotaDevice and method for the endovascular treatment of aneurysms
US6506204 *Dec 29, 2000Jan 14, 2003Aga Medical CorporationMethod and apparatus for occluding aneurysms
US6544276 *Mar 27, 1998Apr 8, 2003Medtronic Ave. Inc.Exchange method for emboli containment
US6589265 *Oct 31, 2000Jul 8, 2003Endovascular Technologies, Inc.Intrasaccular embolic device
US6592614 *Dec 1, 2000Jul 15, 2003Medtronic Ave, Inc.Cuffed endoluminal prosthesis
US6613037 *Apr 4, 2001Sep 2, 2003Farhad KhosraviMethods and apparatus for treating aneurysms and arterio-venous fistulas
US6616684 *Oct 6, 2000Sep 9, 2003Myocor, Inc.Endovascular splinting devices and methods
US6656214 *Jan 16, 1998Dec 2, 2003Medtronic Ave, Inc.Methods and apparatus for conformably sealing prostheses within body lumens
US6663607 *Jul 12, 1999Dec 16, 2003Scimed Life Systems, Inc.Bioactive aneurysm closure device assembly and kit
US6663667 *Oct 31, 2001Dec 16, 2003Edwards Lifesciences CorporationTowel graft means for enhancing tissue ingrowth in vascular grafts
US6712826 *May 17, 2001Mar 30, 2004Cook Vascular IncorporatedApparatus for removing an elongated structure implanted in biological tissue
US6730119 *Oct 6, 2000May 4, 2004Board Of Regents Of The University Of Texas SystemPercutaneous implantation of partially covered stents in aneurysmally dilated arterial segments with subsequent embolization and obliteration of the aneurysm cavity
US6827735 *Mar 2, 2001Dec 7, 2004Cook IncorporatedEndovascular device having a stent
US6843803 *Apr 28, 2003Jan 18, 2005Medtronic Vascular, Inc.Bifurcated intraluminal prostheses construction and methods
US6921410 *May 29, 2001Jul 26, 2005Scimed Life Systems, Inc.Injection molded vaso-occlusive elements
US7530988 *Jul 22, 2005May 12, 2009Nellix, Inc.Methods and systems for endovascular aneurysm treatment
US20010020184 *Mar 27, 2001Sep 6, 2001Mark DehdashtianMethods and apparatus for intraluminal placement of a bifurcated intraluminal graft
US20020019665 *Mar 27, 2001Feb 14, 2002Mark DehdashtianMethods and apparatus for intraluminal placement of a bifurcated intraluminal graft
US20020026217 *Dec 6, 2000Feb 28, 2002Steven BakerApparatus and method for repair of perigraft flow
US20020045848 *May 7, 2001Apr 18, 2002Ali JaafarApparatus and method for treatment of cerebral aneurysms, arterial-vascular malformations and arterial fistulas
US20020052643 *Jan 2, 2001May 2, 2002Wholey Michael H.Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms
US20030051735 *Jul 26, 2002Mar 20, 2003Cook Biotech IncorporatedVessel closure member, delivery apparatus, and method of inserting the member
US20030216802 *Nov 5, 2002Nov 20, 2003Trivascular, Inc.Endovascular graft
US20040044358 *Jun 13, 2003Mar 4, 2004Farhad KhosraviMethods and apparatus for treating aneurysms and arterio-venous fistulas
US20040098027 *Jul 31, 2003May 20, 2004Scimed Life Systems, Inc.Expandable body cavity liner device
US20040116997 *Sep 22, 2003Jun 17, 2004Taylor Charles S.Stent-graft with positioning anchor
US20070050008 *Oct 25, 2006Mar 1, 2007Thomas FogartyDevices and methods for treatment of vascular aneurysms
US20070055355 *Oct 25, 2006Mar 8, 2007Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US20070061005 *Nov 2, 2006Mar 15, 2007Thomas FogartyDevices and methods for treatment of vascular aneurysms
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7666220 *Jul 7, 2006Feb 23, 2010Nellix, Inc.System and methods for endovascular aneurysm treatment
US8048145 *Apr 28, 2006Nov 1, 2011Endologix, Inc.Graft systems having filling structures supported by scaffolds and methods for their use
US8066755Sep 26, 2007Nov 29, 2011Trivascular, Inc.System and method of pivoted stent deployment
US8083789Nov 16, 2007Dec 27, 2011Trivascular, Inc.Securement assembly and method for expandable endovascular device
US8118856Jul 27, 2010Feb 21, 2012Endologix, Inc.Stent graft
US8206430 *Apr 21, 2008Jun 26, 2012Medtronic Vascular, Inc.Endolumenal sealant delivery apparatus and methods
US8216297 *Aug 14, 2006Jul 10, 2012Trivascular, Inc.Dual chamber cuff structure
US8226701Sep 26, 2007Jul 24, 2012Trivascular, Inc.Stent and delivery system for deployment thereof
US8231665Oct 25, 2006Jul 31, 2012Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US8231666Oct 25, 2006Jul 31, 2012Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US8262686Dec 19, 2008Sep 11, 2012Thomas J. FogartyEmbolization device and a method of using the same
US8328861Nov 16, 2007Dec 11, 2012Trivascular, Inc.Delivery system and method for bifurcated graft
US8425548Jun 17, 2011Apr 23, 2013Aneaclose LLCOccluding member expansion and then stent expansion for aneurysm treatment
US8535367Jun 26, 2012Sep 17, 2013Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US8562636Aug 8, 2012Oct 22, 2013Thomas J. FogartyEmbolization device and a method of using the same
US8562662Nov 2, 2006Oct 22, 2013Thomas J. FoartyDevices and methods for treatment of vascular aneurysms
US8647377Oct 29, 2012Feb 11, 2014Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US8663309Sep 26, 2007Mar 4, 2014Trivascular, Inc.Asymmetric stent apparatus and method
US8747597Mar 15, 2011Jun 10, 2014Covidien LpMethods for making braid-ball occlusion devices
US8801768Jan 23, 2012Aug 12, 2014Endologix, Inc.Graft systems having semi-permeable filling structures and methods for their use
US8821564Feb 16, 2012Sep 2, 2014Endologix, Inc.Stent graft
US8870941Oct 31, 2011Oct 28, 2014NellixGraft systems having filling structures supported by scaffolds and methods for their use
US8906057Jan 3, 2011Dec 9, 2014Aneuclose LlcAneurysm embolization by rotational accumulation of mass
US8906084 *Jan 7, 2010Dec 9, 2014Nellix, Inc.System and methods for endovascular aneurysm treatment
US8926681Jan 28, 2011Jan 6, 2015Covidien LpVascular remodeling device
US8926682Sep 23, 2011Jan 6, 2015Nellix, Inc.Stent graft delivery system
US8936633Nov 22, 2013Jan 20, 2015Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US8945199Jun 4, 2009Feb 3, 2015Nellix, Inc.Sealing apparatus and methods of use
US8974487Apr 24, 2009Mar 10, 2015Aneuclose LlcAneurysm occlusion device
US8992595Mar 13, 2013Mar 31, 2015Trivascular, Inc.Durable stent graft with tapered struts and stable delivery methods and devices
US9005235Oct 21, 2013Apr 14, 2015Thomas J. FogartyEmbolization device and a method of using the same
US9039726Oct 25, 2010May 26, 2015Covidien LpFilamentary devices for treatment of vascular defects
US9060886Sep 28, 2012Jun 23, 2015Covidien LpVascular remodeling device
US9089332Mar 23, 2012Jul 28, 2015Covidien LpVascular remodeling device
US9095342Nov 9, 2010Aug 4, 2015Covidien LpBraid ball embolic device features
US9113999Oct 22, 2007Aug 25, 2015Nellix, Inc.Methods for deploying a positioning anchor with a stent-graft
US9138232May 24, 2011Sep 22, 2015Aneuclose LlcAneurysm occlusion by rotational dispensation of mass
US9179918Jul 21, 2009Nov 10, 2015Covidien LpVascular remodeling device
US9289536Mar 7, 2014Mar 22, 2016Endologix, Inc.Method for forming materials in situ within a medical device
US9295569Jan 27, 2014Mar 29, 2016Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US9295571Mar 12, 2013Mar 29, 2016Covidien LpMethods and apparatus for luminal stenting
US9314248Nov 6, 2012Apr 19, 2016Covidien LpMulti-pivot thrombectomy device
US9358098 *Feb 16, 2010Jun 7, 2016Cook Medical Technologies LlcTissue ingrowth anchoring systems and methods and related products
US9358140Dec 7, 2014Jun 7, 2016Aneuclose LlcStent with outer member to embolize an aneurysm
US9393022Aug 8, 2013Jul 19, 2016Covidien LpTwo-stage deployment aneurysm embolization devices
US9393100 *Nov 16, 2011Jul 19, 2016Endologix, Inc.Devices and methods to treat vascular dissections
US9415195Apr 6, 2012Aug 16, 2016Engologix, Inc.Method and system for treating aneurysms
US9463105Mar 14, 2013Oct 11, 2016Covidien LpMethods and apparatus for luminal stenting
US9468442Jan 28, 2011Oct 18, 2016Covidien LpVascular remodeling device
US9468737 *Jul 9, 2014Oct 18, 2016Cook Medical Technologies LlcPerfusion regulation system
US9498363Mar 15, 2013Nov 22, 2016Trivascular, Inc.Delivery catheter for endovascular device
US9561037 *Jul 11, 2011Feb 7, 2017Thomas J. FogartyEmbolization device and a method of using the same
US9561096Mar 26, 2014Feb 7, 2017Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US9561097Oct 3, 2016Feb 7, 2017Thomas J. FogartyDevices and methods for treatment of abdominal aortic aneurysm
US9579103Apr 30, 2010Feb 28, 2017Endologix, Inc.Percutaneous method and device to treat dissections
US9585669May 11, 2012Mar 7, 2017Covidien LpMultiple layer filamentary devices for treatment of vascular defects
US9615912Nov 1, 2012Apr 11, 2017Thomas J. FogartyIntravascular implants and methods of using the same
US9629636Mar 13, 2015Apr 25, 2017Thomas J. FogartyEmbolization device and a method of using the same
US20050245524 *Apr 7, 2005Nov 3, 2005Targegen, Inc.Benzotriazine inhibitors of kinases
US20070050008 *Oct 25, 2006Mar 1, 2007Thomas FogartyDevices and methods for treatment of vascular aneurysms
US20070055355 *Oct 25, 2006Mar 8, 2007Thomas J. FogartyDevices and methods for treatment of vascular aneurysms
US20070061005 *Nov 2, 2006Mar 15, 2007Thomas FogartyDevices and methods for treatment of vascular aneurysms
US20070162106 *Jul 7, 2006Jul 12, 2007Nellix, Inc.System and methods for endovascular aneurysm treatment
US20080058920 *Aug 14, 2006Mar 6, 2008Boston Scientific Scimed, Inc.Dual chamber cuff structure
US20080188923 *Jan 28, 2008Aug 7, 2008Jack Fa-De ChuEndovascular devices to protect aneurysmal wall
US20080228259 *Mar 11, 2008Sep 18, 2008Jack Fa-De ChuEndovascular devices and methods to protect aneurysmal wall
US20080275536 *Apr 30, 2008Nov 6, 2008Zarins Christopher KPrevention of displacement of prosthetic devices within aneurysms
US20080294237 *Feb 26, 2008Nov 27, 2008Jack Fa-De ChuInflatable devices and methods to protect aneurysmal wall
US20090105748 *Dec 19, 2008Apr 23, 2009Thomas J. FogartyEmbolization device and a method of using the same
US20090264821 *Apr 21, 2008Oct 22, 2009Medtronic Vascular, Inc.Endolumenal Sealant Delivery Apparatus and Methods
US20100106087 *Jan 7, 2010Apr 29, 2010Nellix, Inc.System and methods for endovascular aneurysm treatment
US20110202075 *Feb 16, 2010Aug 18, 2011Brian Pak-Yun FengTissue ingrowth anchoring systems and methods and related products
US20120179192 *Jul 11, 2011Jul 12, 2012Fogarty Thomas JEmbolization device and a method of using the same
US20130253632 *Nov 16, 2011Sep 26, 2013Endologix, Inc.Devices and methods to treat vascular dissections
US20140058436 *Feb 16, 2012Feb 27, 2014Sequent Medical, Inc.Blood flow disruption devices and methods for the treatment of vascular defects
US20140243950 *Feb 27, 2014Aug 28, 2014Boston Scientific Scimed, Inc.Stent with balloon for repair of anastomosis surgery leaks
US20150018937 *Jul 9, 2014Jan 15, 2015Cook Medical Technologies LlcPerfusion regulation system
WO2008136999A1 *Apr 30, 2008Nov 13, 2008The Board Of Trustees Of The Leland Stanford Junior UniversityPrevention of displacement of prosthetic devices within aneurysms
WO2014110231A2Jan 9, 2014Jul 17, 2014Trivascular, Inc.Sac liner for aneurysm repair
Classifications
U.S. Classification424/443
International ClassificationA61B, A61K9/70, A61M25/12, A61B17/12, A61B17/34
Cooperative ClassificationA61F2250/0003, A61F2/07, A61B17/12186, A61B17/12036, A61F2/954, A61F2/90, A61B2017/3484, A61B2017/00986, A61B17/12118, A61B2017/00898, A61B17/12195, A61B17/12136, A61F2002/077, A61B17/12022, A61B2017/1205, A61B17/1219, A61F2002/823, A61F2002/065, A61F2/958
European ClassificationA61B17/12P7B, A61B17/12P5B1S, A61B17/12P7Z5, A61B17/12P7Z1, A61B17/12P7Z3, A61B17/12P
Legal Events
DateCodeEventDescription
Mar 7, 2003ASAssignment
Owner name: FOGARTY, THOMAS J., CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KIM, STEVEN W.;SHIU, BRIAN K.;HOLMGREN, NEIL;REEL/FRAME:013863/0504;SIGNING DATES FROM 20030219 TO 20030225